论文部分内容阅读
肿瘤病人细胞免疫功能低下，如何提高细胞免疫功能以杀伤肿瘤细胞，一直是国内外生物学家研究的热点。笔者用重组白细胞介素－2（rIL－2）治疗3例了65例中晚期恶性肿瘤。结果，肿瘤总缓解率为3％，胸腹水总有效率为70％。多数患者临床症状改善，生活质量提高，生存期延长，治疗
The low cellular immune function of cancer patients, how to improve cell immune function to kill tumor cells has been a hot topic for biologists at home and abroad. The author used recombinant interleukin-2 (rIL-2) to treat 3 cases of 65 cases of advanced malignant tumors. As a result, the total tumor remission rate was 3%, and the total effective rate of pleural effusion was 70%. Most patients have improved clinical symptoms, improved quality of life, extended survival, and treatment